Economic Analysis Backs Naldemedine for Opioid Constipation in Cancer Care
In a groundbreaking study from Tsukuba, Japan, researchers have demonstrated that prophylactic administration of naldemedine—a peripherally acting μ-opioid receptor antagonist—offers ...
